跳至主要内容
临床试验/NCT01549457
NCT01549457Unknown1 期

The Effect of Weekly Text-message Communication on Treatment Completion Among Patients With Latent Tuberculosis Infection: a Randomised Controlled Trial (WelTel LTBI)

University of British Columbia3 个研究点 分布在 1 个国家目标入组 350 人开始时间: 2012年4月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
入组人数
350
试验地点
3
主要终点
Successful completion of LTBI treatment regimens.

研究概览

简要总结

This study will examine the impact of use of mobile phones and text messaging on adherence to treatment for patients with latent TB infection. Half (50%) of the 350 anticipated study participants will receive weekly text messages inquiring on their health status in relation to their prescribed treatment, while the other half (50%) will not receive weekly text messages at all. Medical adherence will be assessed by monthly blood-work, clinic visits and by interviewing patients at each of these visits.

The investigators hypothesis is that enhanced communication with a health care provider, via a structured cell phone SMS text messaging based program (WelTel), will result in a 15% improvement in the proportion of patients who successfully complete their LTBI treatment regimens.

详细描述

  1. Purpose

The purpose of this study is to compare the proportion of patients who are adherent to their TB medications among those receiving weekly text messages plus standard of care and those who receive standard of care only. 2. Justification:

Previous research has shown that weekly text messages from a health care provider increases medication adherence for HIV patients. The investigators would like to determine if a similar effect in terms of adherence can be seen in patients receiving medication for latent tuberculosis infection 3. Objectives

Primary Objective:

  1. To compare successful treatment completion rates for patients treated with 9 months of INH or 4 months of RIF between those receiving weekly SMS text messages via mobile phone plus standard of care to those receiving standard care. The standard of care at the TB clinics for all LTBI patients includes provision of a 30 day supply of medications - isoniazid 300mg daily for 9 months months or rifampin 600mg daily for 4 months - at a time, monthly blood-work and monthly clinic visits. Successful treatment completion is defined as taking at least 80% of the doses of INH prescribed within 12 months or at least 80% of the doses of RIF prescribed within 6 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Are initiating treatment for latent TB infection;
  • Are over the age of 18 years old;
  • Own a mobile phone or share access mobile phone access with a household member who consents to participate; AND
  • Demonstrate sufficient ability to communicate via text messaging in English or have a family member or friend that is able to provide translation and assistance with text messaging for the duration of the study

排除标准

  • Individuals under the age of 18;
  • Unable to adequately send and receive text messages for any reason OR
  • Enrolled in another clinical trial that may assess or influence treatment adherence.

研究组 & 干预措施

Non-intervention

No Intervention

Participants will only receive standard of care

Cell phone intervention arm

Experimental

Upon consent, participants will be randomly assigned to receive either 1) standard of care (9 months of INH or 4 months of RIF) and weekly SMS text messages via mobile phone or 2) standard of care (9 months of INH or months of RIF) without weekly SMS text messages via mobile phone.

干预措施: Cell phone text messages (Other)

结局指标

主要结局

Successful completion of LTBI treatment regimens.

时间窗: 4 or 9 months

Successful treatment completion is defined as taking at least 80% of the doses of INH prescribed within 12 months or at least 80% of RIF prescribed within 6 months.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验